According to UNICEF, over a million people die from malaria each year and more so in areas which are more prone to the disease. But researchers have found that a new molecule called TCMDC-135051 has the ability to target the life-cycle of Plasmodium falciparum, a species that causes malaria.
Andre Juliao | Agencia FAPESP – The results of the study, published this Friday (8/30) in Science, pave the way for the development of a new drug against the disease, which has 200,000 new cases and kills nearly half a million people worldwide annually. One of the obstacles to eradicating malaria today is that the parasite has acquired resistance to existing drugs.
Read more on Agencia FAPESP.
(Image credit: mwooten/Pixabay)